• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.

作者信息

Wise R, Andrews J M, Bedford K A

出版信息

J Antimicrob Chemother. 1980 Mar;6(2):197-206. doi: 10.1093/jac/6.2.197.

DOI:10.1093/jac/6.2.197
PMID:6247316
Abstract
摘要

相似文献

1
Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.克拉维酸与CP-45,899：二者与青霉素联合应用的体外活性比较
J Antimicrob Chemother. 1980 Mar;6(2):197-206. doi: 10.1093/jac/6.2.197.
2
A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.头孢哌酮体外活性研究：与其他β-内酰胺类抗生素的比较。
Clin Ther. 1980;3(Spec Issue):149-55.
3
The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acid.
J Antimicrob Chemother. 1979 May;5(3):301-6. doi: 10.1093/jac/5.3.301.
4
Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.克拉维酸与替卡西林联合应用：与其他β-内酰胺类药物的体外比较
J Antimicrob Chemother. 1984 Feb;13(2):121-8. doi: 10.1093/jac/13.2.121.
5
In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis.BRL 17421对流感嗜血杆菌、淋病奈瑟菌和卡他布兰汉菌的体外活性。
Antimicrob Agents Chemother. 1982 Jan;21(1):166-7. doi: 10.1128/AAC.21.1.166.
6
[Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The concept of beta-lactamase inhibitor].[产β-内酰胺酶细菌及其他细菌：哪些需要考虑以及何时考虑？β-内酰胺酶抑制剂的概念]
Presse Med. 1998 Sep;27 Suppl 4:17-8.
7
Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830).哌拉西林与β-内酰胺酶抑制剂他唑巴坦（YTR 830）联合应用的体外比较活性
Diagn Microbiol Infect Dis. 1989 Nov-Dec;12(6):481-8. doi: 10.1016/0732-8893(89)90082-5.
8
Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.哌拉西林与β-内酰胺酶抑制剂联合使用的协同活性。
Antimicrob Agents Chemother. 1980 Oct;18(4):582-5. doi: 10.1128/AAC.18.4.582.
9
In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
J Antimicrob Chemother. 1986 Jan;17(1):125-7. doi: 10.1093/jac/17.1.125.
10
Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs.新型抗假单胞菌广谱青霉素Bay k 4999和哌拉西林与其他β-内酰胺类药物的体外活性比较。
Antimicrob Agents Chemother. 1978 Oct;14(4):549-52. doi: 10.1128/AAC.14.4.549.

引用本文的文献

1
The development of beta-lactam antibiotics in response to the evolution of beta-lactamases.β-内酰胺类抗生素针对β-内酰胺酶的演变而发展。
Pharm Res. 2001 Oct;18(10):1391-9. doi: 10.1023/a:1012272403776.
2
Characterization of a PSE-4 mutant with different properties in relation to penicillanic acid sulfones: importance of residues 216 to 218 in class A beta-lactamases.一种与青霉烷酸砜具有不同性质的PSE-4突变体的特性：A类β-内酰胺酶中216至218位残基的重要性
Antimicrob Agents Chemother. 1998 Sep;42(9):2319-25. doi: 10.1128/AAC.42.9.2319.
3
Pharmacodynamics of ampicillin-sulbactam in an in vitro infection model against Escherichia coli strains with various levels of resistance.
氨苄西林-舒巴坦在针对不同耐药水平大肠杆菌菌株的体外感染模型中的药效学
Antimicrob Agents Chemother. 1998 Feb;42(2):231-5. doi: 10.1128/AAC.42.2.231.
4
Comparison of concentrations of two doses of clavulanic acid (200 and 400 milligrams) administered with amoxicillin (2,000 milligrams) in tissues of patients undergoing colorectal surgery.接受结直肠手术患者的组织中，两种剂量（200毫克和400毫克）克拉维酸与阿莫西林（2000毫克）联合给药后的浓度比较。
Antimicrob Agents Chemother. 1995 Jan;39(1):94-8. doi: 10.1128/AAC.39.1.94.
5
Penicillins. A current review of their clinical pharmacology and therapeutic use.青霉素。对其临床药理学和治疗用途的当前综述。
Drugs. 1993 Jun;45(6):866-894. doi: 10.2165/00003495-199345060-00002.
6
Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.阿莫西林/克拉维酸：抗菌活性、药代动力学及治疗用途综述
Drugs. 1981 Nov;22(5):337-62. doi: 10.2165/00003495-198122050-00001.
7
Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.阴沟肠杆菌和铜绿假单胞菌中的头孢菌素酶截留不可水解头孢菌素作为一种可能的耐药机制。
Antimicrob Agents Chemother. 1982 May;21(5):711-7. doi: 10.1128/AAC.21.5.711.
8
Twenty-one years of beating beta-lactamases.二十一年来对抗β-内酰胺酶
Br Med J (Clin Res Ed). 1982 Feb 6;284(6313):369-70. doi: 10.1136/bmj.284.6313.369.
9
Activities of amoxicillin and clavulanic acid combinations against urinary tract infections.阿莫西林与克拉维酸联合用药对尿路感染的疗效
Antimicrob Agents Chemother. 1982 Aug;22(2):346-9. doi: 10.1128/AAC.22.2.346.
10
In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.替卡西林加克拉维酸对632株临床分离株的体外活性
Antimicrob Agents Chemother. 1984 Mar;25(3):392-4. doi: 10.1128/AAC.25.3.392.